Selskabets formål er at importere, producere, forhandle og eksportere lægemidler samt anden dermed i naturlig forbindelse stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.5 mia. | 17 mio. | 506.7 mio. | 46.4 mio. | 160 | |
CVR: 28964080
Secondary names: Aurora Medical ApS
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Erik Sandberg joined as ADM. DIR.
Ulrik Ernst Rasmussen left as ADM. DIR.
Henrik Bisgaard Jensen left the board
Thomas Hjarsbæk Rasmussen left as director
Companies in the same industry and area
CVR 25615697
CVR 36960566
CVR 16249092
CVR 31605822
CVR 36893419
The financial health of 2CARE4 ApS shows a mixed trajectory, with a notable increase in revenue but a decline in profitability. Revenue rose significantly from 830 million DKK in 2021 to 1.5 billion DKK in 2025, while profit peaked at 48.8 million DKK in 2023 before dropping to 17 million DKK in 2025. The company's equity has decreased from 104.7 million DKK in 2023 to 46.4 million DKK in 2025, raising concerns about its financial stability. Despite its growth in revenue, the declining profit margins and equity position suggest potential challenges ahead in maintaining its competitive stance within the medicinal and healthcare supply industry.
AI-generated summary
companydata.dk